Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 6/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL29657724 | 1.00 | CA1 (0.52) | CA1CA2CA9TDP1CA12 | |
| Trifluoromethanesulfonic Acid SCHEMBL9470710 | 1.00 | CA1 (0.52) | CA1CA2CA9TDP1CA12 | |
| Trifluoromethanesulfonic Acid SCHEMBL576036 | 0.87 | LMNA (0.52) | CA1CA2CA9CA12CA3 | |
| Trifluoromethanesulfonic Acid SCHEMBL1712877 | 0.85 | CA2 (0.53) | CA1CA2CA9TDP1CA12 | |
| Biphenyl SCHEMBL1050411 | 0.83 | PTPN1 (0.58) | CA1CA2CA9CA12PTPN1 | |
| Phenol SCHEMBL8573408 | 0.82 | TDP1 (0.61) | CA1CA2CA9TDP1CA12 | |
| Phenol SCHEMBL138896 | 0.82 | TDP1 (0.69) | CA1CA2CA9TDP1CA12 | |
| Phenol SCHEMBL8801033 | 0.82 | TDP1 (0.69) | CA1CA2CA9TDP1CA12 | |
| Phenol SCHEMBL4576632 | 0.82 | TDP1 (0.69) | CA1CA2CA9TDP1CA12 | |
| Phenol SCHEMBL28121724 | 0.82 | TDP1 (0.69) | CA1CA2CA9TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110903316-B | Phosphonate compound and preparation method and application thereof | 中南大学 | 2021-03-02 | — | — | CN | claimed |
| CN-110903316-A | Phosphonate compound and preparation method and application thereof | 中南大学 | 2020-03-24 | — | — | CN | claimed |
| CN-101503387-B | Preparation of 3-aryl substituted indole containing ester group at 2 site | UNIV ZHEJIANG | 2011-06-15 | — | — | CN | claimed |
| CN-101503387-A | Preparation of 3-aryl substituted indole containing ester group at 2 site | UNIV ZHEJIANG (CN) | 2009-08-12 | — | — | CN | claimed |
| CN-115368223-B | Hydroxy aryl ketone and synthesis method thereof | 中国石油化工股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-115197087-B | Polysubstituted cyclobutene derivative and preparation method thereof | 华东师范大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-115368223-A | Hydroxy arone and synthesis method thereof | 中国石油化工股份有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-115197087-A | Polysubstituted cyclobutene derivatives and process for preparing same | 华东师范大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-114163379-A | Fluorocarbazolyl diphenylethylene biphenyl compound and preparation method and application thereof | 闽都创新实验室 | 2022-03-11 | — | — | CN | disclosed |
| CN-110903316-B | Phosphonate compound and preparation method and application thereof | 中南大学 | 2021-03-02 | — | — | CN | disclosed |
| CN-110903316-A | Phosphonate compound and preparation method and application thereof | 中南大学 | 2020-03-24 | — | — | CN | disclosed |
| US-10266503-B1 | Sulfoxide ligand metal catalyzed oxidation of olefins | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-04-23 | — | — | US | disclosed |
| US-5204344-A | (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes | MERCK FROSST CANADA, INC. (CA) | 1993-04-20 | — | — | US | disclosed |
| EP-0535924-A1 | (Bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis | MERCK FROSST CANADA INC. (CA) | 1993-04-07 | — | — | EP | disclosed |
| EP-0535923-A1 | (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis | MERCK FROSST CANADA INC. (CA) | 1993-04-07 | — | — | EP | disclosed |
| EP-0535926-A1 | (Hetero-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis | MERCK FROSST CANADA INC. (CA) | 1993-04-07 | — | — | EP | disclosed |
| EP-0535925-A1 | (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis | MERCK FROSST CANADA INC. (CA) | 1993-04-07 | — | — | EP | disclosed |
| US-5190968-A | Antiinflammatory | MERCK FROSST CANADA, INC. (CA) | 1993-03-02 | — | — | US | disclosed |
| WO-1992010096-A1 | COMPOUNDS THAT INHIBIT COMPLEMENT AND/OR SUPPRESS IMMUNE ACTIVITY | T CELL SCIENCES, INC. (US) | 1992-06-25 | — | — | WO | disclosed |
| EP-0490587-A1 | Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin II antagonists | MERCK & CO. INC. (US) | 1992-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10266503-B1 | Sulfoxide ligand metal catalyzed oxidation of olefins | YAP1, ICOSLG, SPIN3 | CA1 3255/4885CA2 3802/4885CA9 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.